We maintain our BUY call on Bermaz Auto (BAuto) with an unchanged fair value (FV) of RM1.74/share, based on 13x FY22F EPS. There is no adjustment to our FV for ESG based on our 3-star rating (Exhibit 3).
BAuto’s 9MFY21 core net profit of RM67.1mil came in within our expectations but missed consensus, accounting for 75% and 69% of our full-year forecasts and consensus full-year estimates respectively. Core earnings were down 33% YoY despite an increase in revenue to RM1,646.7mil (+13% YoY). Underlying net profit margin was compressed by 2.8 ppts to 4.1% due to the group’s aggressive promotional campaign – free 6 years of warranty and 6 years of free maintenance – which ends on 31 Dec 2020.
In 9MFY21, BAuto sold a total of 9.8K units of vehicles (+24% YoY) in the domestic market vs. 9MFY20’s 7.9K units. The surge in domestic sales was largely attributed to the Penjana SST exemption from 15 June 2020 to 30 June 2021.
The group’s operations in the Philippines continued to be a notable drag, recording a 9MFY21 total sales volume of only 811 units (-58% YoY). We believe that the weak performance was predominantly due to the Enhanced Community Quarantine (ECQ), a stay-at-home order from 17 March till 1 June 2020. This was followed by the General Community Quarantine (GCQ) on 1 June 2020, in which selected businesses (depending on industry) were allowed to operate at 50% operational capacity.
BAuto’s 30%-owned MMSB sank into a loss of RM5.5mil (- 108% YoY) in 9MFY21 as MMSB sold only 5.9K units vs. 11.7K units in 9MFY20. However, it was partially mitigated by Inokom’s 9MFY21 PAT of RM21.8mil (+127% YoY) despite a lower production volume of 12.5K units (-43% YoY) which led to lower revenue at RM112.2mil (-16% YoY).
BAuto declared a dividend of 3.25 sen/share for 9MFY21, resulting in payout ratio of 56%. We maintain our estimate for FY21F dividend of 4.5 sen, which translates into a yield of 3.4%. The group’s balance sheet continued to improve, sitting on a net cash position of RM354.0mil (or 30.5 sen/share).
We look forward to the introduction of the CX-30 CKD in 2HCY2021 and the potential win of Kia’s manufacturing, assembly and distribution rights, possibly by April 2021. We believe this augurs well for BAuto’s product line-up and will elevate the group’s sales volume along with its profit margins. We estimate the localisation of the CX-30 will reduce the model’s domestic selling price by RM15.0K.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....